Trillium Announces Voting Results from the Annual Meeting

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
269
Trillium Announces Voting Results from the Annual Meeting of Shareholders

TORONTO, ONTARIO--(Marketwired - May 26, 2017) - Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the voting results from its Annual Meeting of shareholders held today. The results of the director elections were as follows:

Name Votes in Favour % Votes in Favour Votes Withheld % Votes Withheld
Mr. Luke Beshar 2,375,427 98.36 39,639 1.64
Dr. Henry Friesen 2,375,627 98.37 39,439 1.63
Dr. Robert Kirkman 2,375,627 98.37 39,439 1.63
Dr. Michael Moore 2,375,527 98.36 39,539 1.64
Dr. Thomas Reynolds 2,375,627 98.37 39,439 1.63
Dr. Niclas Stiernholm 2,376,227 98.39 38,839 1.61
Dr. Calvin Stiller 2,376,111 98.39 38,955 1.61

The shareholders of the Corporation also voted to reappoint Ernst & Young LLP, Chartered Professional Accountants, Licensed Public Accountants as auditors of the Corporation for the ensuing year.

About Trillium Therapeutics

Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The company's lead program, TTI-621, is a SIRPaFc fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin (IgG1). It is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory ("do not eat") signal. Neutralization of the inhibitory CD47 signal enables the activation of macrophage anti-tumor effects by pro-phagocytic ("eat") signals. A Phase 1 clinical trial (NCT02663518) evaluating SIRPaFc is ongoing in advanced hematologic malignancies, and a second Phase 1 trial is underway in solid tumors (NCT02890368). TTI-622 is an IgG4 SIRPaFc protein, which is primarily being developed for combination therapy. An IND filing is targeted for 2H/17. Trillium also has a proprietary medicinal chemistry platform, using unique fluorine chemistry, which permits the creation of new chemical entities from validated drugs and drug candidates with improved pharmacological properties. Stemming from this platform, the company's most advanced preclinical program is an orally-available bromodomain inhibitor, followed by an epidermal growth factor receptor antagonist with increased uptake in the brain. In addition, a number of compounds directed at undisclosed immuno-oncology targets are currently in the discovery phase.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

Company Contact: Trillium Therapeutics Inc. James Parsons Chief Financial Officer 416-595-0627 x232 james@trilliumtherapeutics.com Investor and Media Relations: Canale Communications for Trillium Therapeutics Mark Corbae 619-849-5375 mark@canalecomm.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kentucky Power's Bold Plan to Boost Local Economy

Updated Category News Views 80

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Continue Reading
National Police Assoc. Urges House to Pass PTSD Act

Updated Category News Views 53

An Urgent Call for Action on PTSD Support Alright folks, this ain't your typical investment rundown, but it's got stakes just the same. The National Police Association is sounding the horn for the House to pass the Fighting Post-Traumatic Stress Disorder Act of 2025 (S. 825). Now, if you've been around the block, you know legislation can play out like a market...

Continue Reading
Appier's Q3 FY26 Results: Record Growth and Earnings Spike

Updated Category News Views 146

Appier's Stellar Q3 Performance: A Game Changer Well, ain't that a kicker? Out of the blue, Appier (TSE: 4180) has thrown down a Q3 performance that's got everyone talking. This AI-driven enterprise didn't just ride the wave of success—they created the tsunami. Strap in as we dive into what makes this quarter such a showstopper. Record-Breaking Numbers First off, let's...

Continue Reading
Finding the Right Auto Insurance: What to Consider

Updated Category News Views 52

Understanding the Basics of Auto Insurance Coverage Now, you might think the state knows best when it sets those minimum auto insurance requirements. But let's not kid ourselves—skimping on coverage can leave you high and dry if things go south on the road. That's where an expert voice like Corey Frazer's comes in, laying out why those limits often fall short. Minimum...

Continue Reading
Odessa Water Overbilling Lawsuit Surges Ahead

Updated Category News Views 106

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 44

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
JardogsHealth Taps Industry Titans for Growth Council

Updated Category News Views 82

JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...

Continue Reading
Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Updated Category News Views 123

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...

Continue Reading
Choosing Expert European Auto Repair: Key Insights

Updated Category News Views 11

The Perks of Specialist Knowledge Ever get the feeling your local auto shop doesn't always cut it when your sleek BMW or classy Mercedes needs a tweak? You're not alone. Specifically, for those driving around Alpharetta, European vehicles demand not just routine check-ups but specialist hands. Much like how you wouldn't hand your luxury timepiece to the shop down the...

Continue Reading
Surfshark's No-Logs Policy Gets KPMG Backing

Updated Category News Views 137

Surfshark's Commitment to Privacy Pardon my grizzled voice, but in today's world, where digital privacy often feels like a myth, having a VPN that sticks to its guns about not keeping logs is rare enough to make you look twice. Well, here comes Surfshark, loudly touting yet another seal of approval from one of the Big Four—KPMG. Not the first time for these folks, but...

Continue Reading

Top 5 Most Recently Viewed Articles

Coherent Corp. Showcases Innovative Transceiver Technologies

Updated Category News Views 157

Coherent Corp. Introduces Next-Generation Transceiver Modules Coherent Corp. (NYSE: COHR) has recently captured attention by launching two innovative transceiver modules at the European Conference on Optical Communication (ECOC) 2024. These two models, the 1.6T-DR8 and 800G-DR4 transceivers, are specifically designed to significantly enhance data transmission speeds and...

Continue Reading
Provident Financial Holdings Set to Release Earnings Soon

Updated Category News Views 167

Provident Financial Holdings, Inc. Earnings Release Announcement Provident Financial Holdings, Inc. (Nasdaq: PROV) has recently shared significant news that will cap off their financial quarter. As a holding company for Provident Savings Bank, F.S.B., they are poised to announce their third-quarter earnings soon. This update is eagerly anticipated by both institutional...

Continue Reading
Rivalry Corp. Secures Funds to Propel Future Growth and Innovation

Updated Category News Views 177

Rivalry Corp. Closes Initial Tranche of Private Placement Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), recognized as a leading sportsbook and iGaming operator dedicated to digital-first players, has reached a significant milestone by closing the first tranche of its non-brokered private placement. This announcement follows up...

Continue Reading
Understanding Insider Selling: Lessons From 3 Companies

Updated Category News Views 175

The Implications of Insider Selling Insider selling often triggers investor anxiety—but understanding the context is essential. Recently, sales at Dutch Bros, Monolithic Power Systems, and Palantir Technologies demonstrate that not all insider activity carries the same implications. In this article, we will break down the recent insider sales at these companies and...

Continue Reading
Quantum Corporation Faces Class Action Amid Financial Concerns

Updated Category News Views 173

Quantum Corporation Investors Urged to Act In light of recent challenges faced by Quantum Corporation, shareholders are advised to take note of significant developments that may impact their investments. As investors, it's crucial to stay informed, especially when issues arise that could potentially affect your financial standing. Financial Reporting Issues What Triggered...

Continue Reading